If the FDA determines that the device is NSE due to lack of a predicate, new intended use, or different technology issues at the end of the 510(k) review, the device may be eligible for a De Novo. 510(k) reviewal will follow standard practices, and the NSE letter may indicate that a De Novo classification may be appropriate. The De Novo should be submitted within 30 days.
